TrialThe Lancet. Respiratory medicine2019

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.

Stuart A Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.